NDC 84415-0039-50 — Glycerin 2 g Suppository, 50 suppositories

🆔 Identity & classification

FDA NDC (as labeled) 84415-039-50

Product NDC 84415-039

11-digit billing NDC 84415003950

RxCUI 104155

UNII PDC6A3C0OX

Application # M007

SPL Set ID 5463f869-2b92-4551-e063-6394a90ad6f9

Established class (EPC) Non-Standardized Chemical Allergen

Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production

Chemical class Allergens; Glycerol

DEA schedule Non-controlled

Marketing category OTC MONOGRAPH DRUG

Marketing status On market

FDA listing status Listed (active directory)

Marketing start 2026-06-16

Route RECTAL

Dosage form SUPPOSITORY

Substance GLYCERIN

Why two NDCs? The FDA registers this code as 84415-039-50 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84415-0039-50. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen

Drug family (ATC) Enemas, Other drugs for constipation

Where does this data come from?

Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerEverpharm LLC

FDA applicationM007 (OTC MONOGRAPH DRUG)

Labeler code84415

First marketedJun 2026

Product typeHuman Otc Drug

Portfolio11 products on file

🔎 All NDCs from Everpharm LLC

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an over-the-counter rectal suppository containing glycerin. It is marketed under the FDA's monograph rules for this product category. Glycerin in suppository form is typically used as an osmotic agent to help draw water into the intestines, which commonly supports bowel regularity. This product is meant for rectal insertion.

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

UNII B697894SGQ
Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
UNII QU7E2XA9TG
Sodium stearate is a salt derived from stearic acid, a natural fatty substance. It acts as a lubricant and binder in tablets and capsules, helping the medicine hold together and flow smoothly during manufacturing.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statespolyethylene glycol 400, sodium stearate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?

Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per each	Per package
Retail pharmacies payNADAC · weekly	Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo	No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

ℹ️

No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
Glycerin 2 g 70000-0572-01	Cardinal	25 suppositories	$0.103	—	Availability likely	—
Glycerin 2 g 57237-0325-21	Rising	12 suppositories	$0.217	—	Availability likely	—
Proctozone GMax 2 g 57237-0339-21	Rising	12 suppositories	$0.217	—	Availability likely	—
Fleet 2 g 00132-0075-00	C.B.	100 suppositories	—	—	FDA listed	—
Walgreens Adult Glycerin Laxative 2 g 00363-0445-25	Walgreens	62.5 g	—	—	FDA listed	—
Glycerin 2 g 11822-3312-05	Rite	50 suppositories	—	—	FDA listed	—
Rite-Aid Glycerin Laxative 2 g 11822-9100-00	RITE	100 suppositories	—	—	FDA listed	—
Glycerin Laxative 2 g 13709-0322-01	NeilMed	25 capsules	—	—	FDA listed	—
Glycerin Laxative 2 g/2.5g 13709-0329-01	Neilmed	2.5 g	—	—	FDA listed	—
Glycerin 2 g 37808-0398-50	H	50 suppositories	—	—	FDA listed	—
Stratuscare Adult Glycerin 2 g 58980-0410-12	Stratus	12 suppositories	—	—	FDA listed	—
CVS Pharmacy Glycerin Laxative 2 g 59779-0109-50	CVS	50 suppositories	—	—	FDA listed	—
Glycerin 2 g 68016-0015-79	Chain	25 suppositories	—	—	FDA listed	—
Glycerin 2 g 69842-0724-10	CVS	100 suppositories	—	—	FDA listed	—
Bliss GVS 2 g 72701-0106-05	Bliss	100 suppositories	—	—	FDA listed	—
Glycerin 2 gthis 84415-0039-50	Everpharm	50 suppositories	—	—	FDA listed	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

2026

On the market since

Jun 2026

📍

2026

Currently FDA-listed

listed with the FDA

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDC	Description	Marketing start	Status
84415-0039-50 You're viewing this	50 POUCH in 1 CARTON (84415-039-50) / 1 SUPPOSITORY in 1 POUCH	2026-06-16	Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product

What data is (and isn’t) available for this NDC — tap to expand

NDC identity (package / product / labeler codes)	✓ Available
Labeler	✓ Available
Product & package description	✓ Available
Marketing category & status	✓ Available
Active ingredient / dosage form / route	✓ Available
FDA label (SPL via DailyMed)	✓ Available
Package photos	— Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured)	✓ Available
NADAC pharmacy acquisition price (CMS)	— Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data	— Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk	— Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)	— Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.

“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?

An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.

Why is there no price listed?

The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.

Is the NDC printed on the package the same as the 11-digit billing NDC?

Yes, they identify this exact package in different formats. The FDA registers it as 84415-039-50, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 84415-0039-50, written without dashes as 84415003950. The Identity section at the top of this page lists every form of this code.

What do the three segments of this NDC mean?

In 84415-0039-50, the first segment (84415) is the labeler code FDA assigned to Everpharm LLC; the middle segment (0039) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (50) identifies this exact package size and type. Together they name one specific package of one specific product.

Is this package still being marketed?

Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Everpharm LLC. Listing status can change — the directory data on this page refreshes weekly.

Who lists this product with the FDA?

Everpharm LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.

Do I need a prescription for this product?

This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.

This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.

Where does this data come from?

Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 18 words ▾

Uses For relief of occasional constipation. This product usually produces a bowel movement in ¼ to 1 hour.

⏱️ Dosage and Administration 99 words ▾

Directions Single Daily dosage: 1 suppository or as directed by a doctor Adults and children 6 years and over tear wrapper prior to immediate use remove the secondary wrapper before inserting into the rectum as follows: hold suppository with pointed end up carefully separate tabs with fingernail - gently pull apart by pulling tabs down on both sides - remove suppository from wrapper - insert one suppository well up into the rectum Children 2 to 6 years use Children's Glycerin Suppositories Children under 2 years of age: ask a doctor Suppository need not melt completely to produce laxative action

⚠️ Warnings 120 words ▾

Warnings For rectal use only. Do not use laxative products when abdominal pain, nausea or vomiting are present unless directed by a doctor Ask a doctor before use if you have a sudden change in bowel habits lasting more than 2 weeks. already used a laxative for more than 1 week. When using this product rectal discomfort or burning sensation may occur Stop using this product and consult a doctor if you have rectal bleeding no bowel movement within 1 hour of using this product This may indicate a serious condition.

If pregnant or breastfeeding, ask a doctor before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 9 words ▾

Active ingredient (in each suppository) Glycerin, USP 2 g

🧪 Inactive Ingredients 7 words ▾

Inactive ingredients polyethylene glycol 400, sodium stearate

🎯 Purpose 3 words ▾

Purpose Hyperosmotic laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Glycerin Suppository NDCsSame ingredient 🏭 All Everpharm labeler NDCsLabeler code 84415 📚 All Non-Standardized Chemical Allergen NDCsDrug class 📖 Read the Glycerin Suppository drug informationUses, warnings & side effects